deltatrials
Completed PHASE3 NCT00650091

Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF

Prednisone, Azathioprine, and N-acetylcysteine: A Study That Evaluates Response in IPF

Sponsor: Duke University

Conditions Pulmonary Fibrosis
Interventions N-acetylcysteine (NAC) Placebo
Updated 6 times since 2017 Last updated: May 27, 2015 Started: Oct 31, 2009 Primary completion: Oct 31, 2013 Completion: Jan 31, 2014

This PHASE3 trial investigates Pulmonary Fibrosis and is currently completed. Duke University leads this study, which shows 6 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE3

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE3

    First recorded

Oct 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Duke University
  • National Heart, Lung, and Blood Institute (NHLBI)
Data source: Duke University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ann Arbor, United States, Birmingham, United States, Boston, United States, Charleston, United States, Chesterfield, United States, Chicago, United States, Cleveland, United States, Dallas, United States, Denver, United States, Durham, United States and 12 more location s